Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
This report contains market size and forecasts of Iohexol API in global, including the following market information:
Global Iohexol API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Iohexol API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Iohexol API companies in 2021 (%)
The global Iohexol API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Original Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Iohexol API include GE Healthcare, BeiLu Pharma, Fuji Pharma, Stellite and Haichang Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Iohexol API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Iohexol API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iohexol API Market Segment Percentages, by Type, 2021 (%)
Original Drug
Generic Drug
Global Iohexol API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iohexol API Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Iohexol API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iohexol API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Iohexol API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Iohexol API revenues share in global market, 2021 (%)
Key companies Iohexol API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Iohexol API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
BeiLu Pharma
Fuji Pharma
Stellite
Haichang Pharmaceutical